Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action

Rafael Ceña-Diez,1,* Enrique Vacas-Córdoba,1,* Pilar García-Broncano,1,2 FJ de la Mata,3 Rafael Gómez,3 Marek Maly,4 Mª Ángeles Muñoz-Fernández11Molecular Immunobiology Laboratory, General Universitary Hospital Gre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ceña-Diez R, Vacas-Córdoba E, García-Broncano P, de la Mata FJ, Gómez R, Maly M, Muñoz-Fernández MA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/3cd9feabc3fe4a33b36064a67fe2383c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3cd9feabc3fe4a33b36064a67fe2383c
record_format dspace
spelling oai:doaj.org-article:3cd9feabc3fe4a33b36064a67fe2383c2021-12-02T03:11:38ZPrevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action1178-2013https://doaj.org/article/3cd9feabc3fe4a33b36064a67fe2383c2016-05-01T00:00:00Zhttps://www.dovepress.com/prevention-of-vaginal-and-rectal-herpes-simplex-virus-type-2-transmiss-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Rafael Ceña-Diez,1,* Enrique Vacas-Córdoba,1,* Pilar García-Broncano,1,2 FJ de la Mata,3 Rafael Gómez,3 Marek Maly,4 Mª Ángeles Muñoz-Fernández11Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 2Viral and Immune Infection Unit Center, Institute of Health Carlos III, Majadahonda Campus, Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, 3Organic and Inorganic Chemistry Department, Alcala University, University Campus Alcala de Heneras, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; 4Faculty of Science, J.E. Purkinje University, Ústí nad Labem, Czech Republic*These authors contributed equally to this work Abstract: Topical microbicides to stop sexually transmitted diseases, such as herpes simplex virus type 2 (HSV-2), are urgently needed. The emerging field of nanotechnology offers novel suitable tools for addressing this challenge. Our objective was to study, in vitro and in vivo, antiherpetic effect and antiviral mechanisms of several polyanionic carbosilane dendrimers with anti-HIV-1 activity to establish new potential microbicide candidates against sexually transmitted diseases. Plaque reduction assay on Vero cells proved that G2-S16, G1-S4, and G3-S16 are the dendrimers with the highest inhibitory response against HSV-2 infection. We also demonstrated that our dendrimers inhibit viral infection at the first steps of HSV-2 lifecycle: binding/entry-mediated events. G1-S4 and G3-S16 bind directly on the HSV-2, inactivating it, whereas G2-S16 adheres to host cell-surface proteins. Molecular modeling showed that G1-S4 binds better at binding sites on gB surface than G2-S16. Significantly better binding properties of G1-S4 than G2-S16 were found in an important position for affecting transition of gB trimer from G1-S4 prefusion to final postfusion state and in several positions where G1-S4 could interfere with gB/gH–gL interaction. We demonstrated that these polyanionic carbosilan dendrimers have a synergistic activity with acyclovir and tenofovir against HSV-2, in vitro. Topical vaginal or rectal administration of G1-S4 or G2-S16 prevents HSV-2 transmission in BALB/c mice in values close to 100%. This research represents the first demonstration that transmission of HSV-2 can be blocked by vaginal/rectal application of G1-S4 or G2-S16, providing a step forward to prevent HSV-2 transmission in humans.Keywords: nanotechnology, dendrimers, G1-S4, G2-S16, HSV-2, microbicideCeña-Diez RVacas-Córdoba EGarcía-Broncano Pde la Mata FJGómez RMaly MMuñoz-Fernández MADove Medical PressarticlenanotechnologydendrimersG1-S4G2-S16HSV-2microbicideMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2016, Iss default, Pp 2147-2162 (2016)
institution DOAJ
collection DOAJ
language EN
topic nanotechnology
dendrimers
G1-S4
G2-S16
HSV-2
microbicide
Medicine (General)
R5-920
spellingShingle nanotechnology
dendrimers
G1-S4
G2-S16
HSV-2
microbicide
Medicine (General)
R5-920
Ceña-Diez R
Vacas-Córdoba E
García-Broncano P
de la Mata FJ
Gómez R
Maly M
Muñoz-Fernández MA
Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
description Rafael Ceña-Diez,1,* Enrique Vacas-Córdoba,1,* Pilar García-Broncano,1,2 FJ de la Mata,3 Rafael Gómez,3 Marek Maly,4 Mª Ángeles Muñoz-Fernández11Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 2Viral and Immune Infection Unit Center, Institute of Health Carlos III, Majadahonda Campus, Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, 3Organic and Inorganic Chemistry Department, Alcala University, University Campus Alcala de Heneras, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; 4Faculty of Science, J.E. Purkinje University, Ústí nad Labem, Czech Republic*These authors contributed equally to this work Abstract: Topical microbicides to stop sexually transmitted diseases, such as herpes simplex virus type 2 (HSV-2), are urgently needed. The emerging field of nanotechnology offers novel suitable tools for addressing this challenge. Our objective was to study, in vitro and in vivo, antiherpetic effect and antiviral mechanisms of several polyanionic carbosilane dendrimers with anti-HIV-1 activity to establish new potential microbicide candidates against sexually transmitted diseases. Plaque reduction assay on Vero cells proved that G2-S16, G1-S4, and G3-S16 are the dendrimers with the highest inhibitory response against HSV-2 infection. We also demonstrated that our dendrimers inhibit viral infection at the first steps of HSV-2 lifecycle: binding/entry-mediated events. G1-S4 and G3-S16 bind directly on the HSV-2, inactivating it, whereas G2-S16 adheres to host cell-surface proteins. Molecular modeling showed that G1-S4 binds better at binding sites on gB surface than G2-S16. Significantly better binding properties of G1-S4 than G2-S16 were found in an important position for affecting transition of gB trimer from G1-S4 prefusion to final postfusion state and in several positions where G1-S4 could interfere with gB/gH–gL interaction. We demonstrated that these polyanionic carbosilan dendrimers have a synergistic activity with acyclovir and tenofovir against HSV-2, in vitro. Topical vaginal or rectal administration of G1-S4 or G2-S16 prevents HSV-2 transmission in BALB/c mice in values close to 100%. This research represents the first demonstration that transmission of HSV-2 can be blocked by vaginal/rectal application of G1-S4 or G2-S16, providing a step forward to prevent HSV-2 transmission in humans.Keywords: nanotechnology, dendrimers, G1-S4, G2-S16, HSV-2, microbicide
format article
author Ceña-Diez R
Vacas-Córdoba E
García-Broncano P
de la Mata FJ
Gómez R
Maly M
Muñoz-Fernández MA
author_facet Ceña-Diez R
Vacas-Córdoba E
García-Broncano P
de la Mata FJ
Gómez R
Maly M
Muñoz-Fernández MA
author_sort Ceña-Diez R
title Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
title_short Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
title_full Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
title_fullStr Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
title_full_unstemmed Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
title_sort prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/3cd9feabc3fe4a33b36064a67fe2383c
work_keys_str_mv AT centildeadiezr preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
AT vacascoacuterdobae preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
AT garciacuteabroncanop preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
AT delamatafj preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
AT goacutemezr preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
AT malym preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
AT muntildeozfernaacutendezma preventionofvaginalandrectalherpessimplexvirustype2transmissioninmicemechanismofantiviralaction
_version_ 1718401911321788416